Revvity Inc. $RVTY Shares Sold by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. decreased its holdings in shares of Revvity Inc. (NYSE:RVTY) by 25.3% in the 4th quarter, Holdings Channel reports. The firm owned 26,397 shares of the company’s stock after selling 8,929 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Revvity were worth $2,554,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of RVTY. New York Life Investment Management LLC grew its position in shares of Revvity by 72.7% during the 3rd quarter. New York Life Investment Management LLC now owns 27,520 shares of the company’s stock valued at $2,412,000 after buying an additional 11,583 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Revvity by 15.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 511,360 shares of the company’s stock valued at $44,821,000 after purchasing an additional 67,662 shares during the period. Tudor Investment Corp ET AL acquired a new position in Revvity during the 3rd quarter valued at approximately $15,128,000. First National Bank of Omaha acquired a new position in Revvity during the 3rd quarter valued at approximately $6,432,000. Finally, Elo Mutual Pension Insurance Co boosted its position in Revvity by 46.2% during the 3rd quarter. Elo Mutual Pension Insurance Co now owns 19,199 shares of the company’s stock valued at $1,683,000 after purchasing an additional 6,066 shares during the period. 86.65% of the stock is currently owned by institutional investors.

Revvity Trading Up 3.8%

Shares of RVTY stock opened at $104.09 on Wednesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $118.30. The stock has a fifty day moving average of $94.07 and a two-hundred day moving average of $97.67. The firm has a market capitalization of $11.61 billion, a PE ratio of 49.81, a price-to-earnings-growth ratio of 2.19 and a beta of 1.11.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The company had revenue of $711.12 million during the quarter, compared to analyst estimates of $704.07 million. During the same quarter in the previous year, the firm posted $1.01 EPS. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, research analysts expect that Revvity Inc. will post 5.25 EPS for the current year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Friday, July 17th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is 13.40%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on RVTY. Barclays boosted their price objective on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Weiss Ratings lowered Revvity from a “sell (d+)” rating to a “sell (d)” rating in a research report on Wednesday, May 13th. Wolfe Research began coverage on Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. TD Cowen boosted their price objective on Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. reduced their price objective on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Four analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.